YS Biopharma Co., Ltd. (YS) has a market capitalization of $192.09M and trades at $1.02. The 52-week range is 0.3503-1.78.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -1.1, Earnings Per Share (EPS) of $-0.94, annual revenue of $614.96M.
The stock has a beta of 0.54, operates in the Healthcare sector.
